Category Archives: Prescribing Newsletter

COVID-19 – Professional Resources & Guidance

NHS England COVID-19 Guidance – NHS England COVID-19 Specialty Guides  UK Government COVID-19 resources – NHS COVID-19 resources NICE COVID-19 resources – NHS SPS COVID-19 resources – RDTC HEE e-Learning for Health COVID-19 Courses Medicines for End of Life & Critical Care Alphabetical List – with thanks to SPS Several Professional, Academic & Representative Bodies have compiled collections of COVID-19 guidance Continue Reading »

COVID-19 – Warfarin

The NHS Specialist Pharmacy Service have published a guide to Management of patients taking warfarin during the COVID-19 pandemic. [See also: Guidance for Safe Switching of Warfarin to DOACs] The guide recommends a stepwise approach: For patients with prior DVT or PE with low risk of recurrence, consider stopping warfarin. For other patients, consider switching to a DOAC Continue Reading »

COVID-19 – Anticoagulant Services Clinical Guide

NHSE&I have published a Clinical guide for the management of anticoagulant services during the coronavirus pandemic – as part of the NHSE&I COVID-19 Collection of Specialty Guides  Patients receiving warfarin requiring management in outpatient or community settings – Anticoagulation service provision should consider the following: Is warfarin still required? Can patients on warfarin be switched to an alternative Continue Reading »

COVID-19 – Drug Monitoring Guidance

The NHS Specialist Pharmacy Service have published Guidance on management of drugs requiring monitoring during COVID-19 – supported by background advice on General Factors to Consider when making Monitoring Decisions. The objective of the guidance is to protect patients from unnecessary health care visits and help preserve capacity in primary care.  The SPS guide recommends that drug monitoring during Continue Reading »